Search

Author/Creator Maio, M

1. 1138PDFirst in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1. (23rd October 2018)

Authors:
Hansen, A; Bauer, T M; Moreno, V; Maio, M; Groenland, S; Martin-Liberal, J; Gan, H; Rischin, D; Millward, M; Olszanski, A J; Cho, D C; Paul, E; Ballas, M; Ellis, C; Zhou, H; Yadavilli, S; Sadik Shaik, J; Schmidt, E V; Hoos, A; Angevin, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 900PInterim results of fight-201, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with metastatic or surgically unresectable urothelial carcinoma (UC) harboring fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations (GA). (23rd October 2018)

Authors:
Necchi, A; Pouessel, D; Leibowitz-Amit, R; Flechon, A; Gupta, S; Barthelemy, P; Maio, M; Zhu, X; Asatiani, E; Serbest, G; Zhen, H; Loriot, Y
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab. (30th March 2017)

Authors:
Ferrucci, P F; Ascierto, P A; Pigozzo, J; Del Vecchio, M; Maio, M; Antonini Cappellini, G C; Guidoboni, M; Queirolo, P; Savoia, P; Mandalà, M; Simeone, E; Valpione, S; Altomonte, M; Spagnolo, F; Cocorocchio, E; Gandini, S; Giannarelli, D; Martinoli, C
Journal:
Annals of oncology
Issue:
Volume 29:Number 2(2018)
Page Start:
524
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP). (7th November 2013)

Authors:
Ascierto, Paolo Antonio; Simeone, E; Sileni, V Chiarion; Queirolo, P; Del Vecchio, M; Di Guardo, L; Guidoboni, M; Marchetti, P; Cappellini, GC Antonini; Ferrucci, PF; Cognetti, F; Bernengo, MG; Guida, M; Marconcini, R; Mandalà, M; Cimminiello, C; Rinaldi, G; Aglietta, M; Calabrò, L; Maio, M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗